Lake Street lowered the firm’s price target on Alkami (ALKT) to $34 from $41 and keeps a Buy rating on the shares. Alkami fell short of Q3 revenue expectations due to shifting go-lives but “nicely beat” adjusted EBITDA expectations, the analyst tells investors. Alkami’s shifting Q3 add on go-lives “have created an attractive buying opportunity for investors on what was otherwise a solid quarter fundamentally,” adds the analyst, who views this “growth stock as a name to own on weakness.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKT:
- Alkami price target lowered to $38 from $40 at JPMorgan
- Alkami Technology: Buy Rating Affirmed Amid Strong Fundamentals and Attractive Valuation
- Alkami price target lowered to $40 from $46 at Citizens JMP
- Alkami price target lowered to $25 from $30 at Barclays
- Alkami Technology Reports Strong Q3 2025 Results
